Appili Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	0.04	1.23	0.09	2.47	6.66
Cash & Short-Term Investments	0.04	1.23	0.09	2.47	6.66
Cash Growth	-96.74%	1199.82%	-96.17%	-63.00%	-58.67%
Accounts Receivable	1.79	1.66	1.16	0.12	0.47
Other Receivables	0.01	0.01	0.02	0.3	0.92
Total Trade Receivables	1.8	1.67	1.17	0.42	1.39
Other Current Assets	0.12	0.11	0.19	0.23	0.18
Total Current Assets	1.96	3.01	1.46	3.12	8.24
Net Property, Plant & Equipment	0.01	0.02	0.03	0.01	0.04
Total Assets	1.97	3.03	1.49	3.13	8.28
Accounts Payable	6.3	4.11	4.18	2.82	6.46
Current Portion of Long-Term Debt	12.26	11.56	7.31	0.11	0.1
Unearned Revenue	-	-	-	-	0.12
Other Current Liabilities	0.06	0.03	0.05	0.04	-
Total Current Liabilities	18.63	15.69	11.54	2.98	6.67
Long-Term Debt	0.67	0.74	0.88	7.55	4.88
Total Long-Term Liabilities	0.67	0.74	0.88	7.55	4.88
Total Liabilities	19.3	16.43	12.42	10.53	11.55
Shareholders' Equity	-17.33	-13.4	-10.92	-7.4	-3.27
Total Liabilities & Equity	1.97	3.03	1.49	3.13	8.28
Total Debt	12.94	12.29	8.18	7.67	4.98
Net Cash (Debt)	-12.9	-11.07	-8.09	-5.2	1.69
Net Cash Growth	-	-	-	-	-88.83%
Net Cash Per Share	-0.10	-0.09	-0.07	-0.05	0.03